Thus, longitudinal data does not show BACE1, Ng or Ng/BACE1 changes coinciding with stage-wise Alzheimer’s disease progression but gives evidence of lasting differences between cases over the observation period, also with increasing core pathologies. This evidence concerns the gene NRGN and early-onset autosomal dominant Alzheimer disease.